These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. CD8 Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G Front Immunol; 2021; 12():764949. PubMed ID: 35116022 [TBL] [Abstract][Full Text] [Related]
10. Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8 van den Dijssel J; Hagen RR; de Jongh R; Steenhuis M; Rispens T; Geerdes DM; Mok JY; Kragten AH; Duurland MC; Verstegen NJ; van Ham SM; van Esch WJ; van Gisbergen KP; Hombrink P; Ten Brinke A; van de Sandt CE Clin Transl Immunology; 2022; 11(10):e1423. PubMed ID: 36254196 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity. Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447 [TBL] [Abstract][Full Text] [Related]
13. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Grifoni A; Weiskopf D; Ramirez SI; Mateus J; Dan JM; Moderbacher CR; Rawlings SA; Sutherland A; Premkumar L; Jadi RS; Marrama D; de Silva AM; Frazier A; Carlin AF; Greenbaum JA; Peters B; Krammer F; Smith DM; Crotty S; Sette A Cell; 2020 Jun; 181(7):1489-1501.e15. PubMed ID: 32473127 [TBL] [Abstract][Full Text] [Related]
14. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892 [TBL] [Abstract][Full Text] [Related]
19. Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals. Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AA bioRxiv; 2021 Dec; ():. PubMed ID: 34909772 [TBL] [Abstract][Full Text] [Related]
20. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population. Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L Front Immunol; 2024; 15():1357731. PubMed ID: 38784379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]